Form D — Oric Pharmaceuticals, Inc.
0001796280-25-000001 · filed Jun 6, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $125,000,000
- Total sold
- $125,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Oric Pharmaceuticals, Inc.
- CIK
- 1796280
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 240 E. GRAND AVE.
SOUTH SAN FRANCISCO, CA 94080 - Phone
- (650) 388-5600
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jacob M. Chacko · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Pratik Multani · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Dominic Piscitelli · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Richard Heyman · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Mardi C. Dier · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Steve L. Hoerter · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Lori Kunkel · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Angie You · DirectorSouth San Francisco, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗